These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 16860501)
21. Influence of polyethylene glycol chain length on the physicochemical and biological properties of poly(ethylene imine)-graft-poly(ethylene glycol) block copolymer/SiRNA polyplexes. Mao S; Neu M; Germershaus O; Merkel O; Sitterberg J; Bakowsky U; Kissel T Bioconjug Chem; 2006; 17(5):1209-18. PubMed ID: 16984130 [TBL] [Abstract][Full Text] [Related]
22. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anticancer immune response. Alshamsan A; Haddadi A; Hamdy S; Samuel J; El-Kadi AO; Uludağ H; Lavasanifar A Mol Pharm; 2010 Oct; 7(5):1643-54. PubMed ID: 20804176 [TBL] [Abstract][Full Text] [Related]
24. Interaction of DNA/nuclear protein/polycation and the terplexes for gene delivery. Shen Y; Peng H; Pan S; Feng M; Wen Y; Deng J; Luo X; Wu C Nanotechnology; 2010 Jan; 21(4):045102. PubMed ID: 20009166 [TBL] [Abstract][Full Text] [Related]
25. Targeted PLGA nano- but not microparticles specifically deliver antigen to human dendritic cells via DC-SIGN in vitro. Cruz LJ; Tacken PJ; Fokkink R; Joosten B; Stuart MC; Albericio F; Torensma R; Figdor CG J Control Release; 2010 Jun; 144(2):118-26. PubMed ID: 20156497 [TBL] [Abstract][Full Text] [Related]
26. Delivery of rapamycin by PLGA nanoparticles enhances its suppressive activity on dendritic cells. Haddadi A; Elamanchili P; Lavasanifar A; Das S; Shapiro J; Samuel J J Biomed Mater Res A; 2008 Mar; 84(4):885-98. PubMed ID: 17647224 [TBL] [Abstract][Full Text] [Related]
27. PEGylated-PLGA microparticles containing VEGF for long term drug delivery. Simón-Yarza T; Formiga FR; Tamayo E; Pelacho B; Prosper F; Blanco-Prieto MJ Int J Pharm; 2013 Jan; 440(1):13-8. PubMed ID: 22814223 [TBL] [Abstract][Full Text] [Related]
28. Biodegradable nanoparticles modified by branched polyethylenimine for plasmid DNA delivery. Son S; Kim WJ Biomaterials; 2010 Jan; 31(1):133-43. PubMed ID: 19783041 [TBL] [Abstract][Full Text] [Related]
29. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells. Cruz LJ; Tacken PJ; Fokkink R; Figdor CG Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247 [TBL] [Abstract][Full Text] [Related]
30. Anti-GAD antibody targeted non-viral gene delivery to islet beta cells. Jeong JH; Lee M; Kim WJ; Yockman JW; Park TG; Kim YH; Kim SW J Control Release; 2005 Oct; 107(3):562-70. PubMed ID: 16139384 [TBL] [Abstract][Full Text] [Related]
31. In vivo tumor targeting of tumor necrosis factor-alpha-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Fang C; Shi B; Pei YY; Hong MH; Wu J; Chen HZ Eur J Pharm Sci; 2006 Jan; 27(1):27-36. PubMed ID: 16150582 [TBL] [Abstract][Full Text] [Related]
32. Galactose-poly(ethylene glycol)-polyethylenimine for improved lung gene transfer. Chen J; Gao X; Hu K; Pang Z; Cai J; Li J; Wu H; Jiang X Biochem Biophys Res Commun; 2008 Oct; 375(3):378-83. PubMed ID: 18694731 [TBL] [Abstract][Full Text] [Related]
33. Intracellular uptake and release of poly(ethyleneimine)-co-poly(methyl methacrylate) nanoparticle/pDNA complexes for gene delivery. Feng M; Lee D; Li P Int J Pharm; 2006 Mar; 311(1-2):209-14. PubMed ID: 16442245 [TBL] [Abstract][Full Text] [Related]
34. Bioreversibly crosslinked polyplexes of PEI and high molecular weight PEG show extended circulation times in vivo. Neu M; Germershaus O; Behe M; Kissel T J Control Release; 2007 Dec; 124(1-2):69-80. PubMed ID: 17897749 [TBL] [Abstract][Full Text] [Related]
35. DC3-decorated polyplexes for targeted gene delivery into dendritic cells. Golani-Armon A; Golan M; Shamay Y; Raviv L; David A Bioconjug Chem; 2015 Feb; 26(2):213-24. PubMed ID: 25560976 [TBL] [Abstract][Full Text] [Related]
36. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells. Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213 [TBL] [Abstract][Full Text] [Related]
37. Supramolecular control of polyplex dissociation and cell transfection: efficacy of amino groups and threading cyclodextrins in biocleavable polyrotaxanes. Yamashita A; Kanda D; Katoono R; Yui N; Ooya T; Maruyama A; Akita H; Kogure K; Harashima H J Control Release; 2008 Oct; 131(2):137-44. PubMed ID: 18700157 [TBL] [Abstract][Full Text] [Related]
38. Polyplex micelles prepared from ω-cholesteryl PEG-polycation block copolymers for systemic gene delivery. Oba M; Miyata K; Osada K; Christie RJ; Sanjoh M; Li W; Fukushima S; Ishii T; Kano MR; Nishiyama N; Koyama H; Kataoka K Biomaterials; 2011 Jan; 32(2):652-63. PubMed ID: 20932567 [TBL] [Abstract][Full Text] [Related]
39. A biodegradable low molecular weight polyethylenimine derivative as low toxicity and efficient gene vector. Wen Y; Pan S; Luo X; Zhang X; Zhang W; Feng M Bioconjug Chem; 2009 Feb; 20(2):322-32. PubMed ID: 19152330 [TBL] [Abstract][Full Text] [Related]
40. Differential effects of agarose and poly(lactic-co-glycolic acid) on dendritic cell maturation. Yoshida M; Babensee JE J Biomed Mater Res A; 2006 Nov; 79(2):393-408. PubMed ID: 16886225 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]